PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Mounting Clinical Evidence Underlines Benefits of Bone Growth and Spinal Fusion Stimulators According to Frost & Sullivan - The demand for a reliable, non-invasive, efficient and cost-effective technology that improves patients' lifestyles is boosting interest in bone growth and spinal fusion stimulators in Europe
Mounting Clinical Evidence Underlines Benefits of Bone Growth and Spinal Fusion Stimulators According to Frost & Sullivan

 

NewswireToday - /newswire/ - London, United Kingdom, 2009/03/05 - The demand for a reliable, non-invasive, efficient and cost-effective technology that improves patients' lifestyles is boosting interest in bone growth and spinal fusion stimulators in Europe.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The market is however still small, as clinicians have felt that the technology needs to be better proved. This situation is changing though, as companies introduce innovative products with clinical studies and research papers to substantiate the efficacy of their offerings.

New analysis from Frost & Sullivan (medicaldevices.frost.com), European Bone Growth and Spinal Fusion Stimulators Markets, finds that the markets earned revenues of $73.5 million in 2007 and estimates this to reach $118.0 million by 2014.

"An increasing number of scientific research studies support these technologies," notes a Frost & Sullivan analyst. "Each year, manufacturers and independent researchers are publishing more papers, describing in greater detail how stimulation has beneficial effects and which types of patients can best benefit from this treatment."

There is still a great deal of debate among orthopaedicians about what dosage of stimulation is optimal for a given patient with a given condition. However, most of them now agree that the technology is able to produce good results in most selected patients.

Reimbursement still remains an issue for the market, but some hospitals are now including bone growth stimulation in their budgets. Although used primarily for treating worst-case failures, they are gradually gaining acceptance as an alternative to non-union surgery.

"This technology has met with much resistance in Europe, but as clinical experience is gained, bone growth stimulation will be regarded as a good option at the surgeon's disposal in the future," states the analyst. "Patients tend to get coverage from private or public insurance for other treatments, yet for bone and spinal fusion stimulators no coverage is offered, giving patients the impression that one treatment is better or more accepted than the other."

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the European bone growth and spinal fusion stimulators markets, then send an email to Katja Feick, Corporate Communications, at katja.feick[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.

European Bone Growth and Spinal Fusion Stimulators Markets is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following markets: European Markets for Bone Grafts and Bone Cements and Issues and Trends in Infection Control Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan (frost.com), the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

European Bone Growth and Spinal Fusion Stimulators Markets / M281

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Mounting Clinical Evidence Underlines Benefits of Bone Growth and Spinal Fusion Stimulators According to Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Katja Feick 
+49 (0) 69 7703343 katja.feick[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove
GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
Insulin Delivery Devices Market Size to Expand at 7% CAGR through 2020 Says PMR
Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)